JPMorgan Chase & Co’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Sell |
206,107
-369,512
| -64% | -$7.86M | ﹤0.01% | 2794 |
|
|
2025
Q1 | $11.1M | Buy |
575,619
+436,038
| +312% | +$8.41M | ﹤0.01% | 2104 |
|
|
2024
Q4 | $2.49M | Sell |
139,581
-23,068
| -14% | -$412K | ﹤0.01% | 3258 |
|
|
2024
Q3 | $3.56M | Sell |
162,649
-1,101
| -0.7% | -$24.1K | ﹤0.01% | 2855 |
|
|
2024
Q2 | $1.28M | Sell |
163,750
-85,917
| -34% | -$670K | ﹤0.01% | 3369 |
|
|
2024
Q1 | $1.03M | Sell |
249,667
-46,538
| -16% | -$193K | ﹤0.01% | 3551 |
|
|
2023
Q4 | $773K | Buy |
296,205
+82,391
| +39% | +$215K | ﹤0.01% | 3677 |
|
|
2023
Q3 | $400K | Buy |
213,814
+97,399
| +84% | +$182K | ﹤0.01% | 3839 |
|
|
2023
Q2 | $292K | Buy |
116,415
+93,311
| +404% | +$234K | ﹤0.01% | 4065 |
|
|
2023
Q1 | $40K | Buy |
23,104
+9,522
| +70% | +$16.5K | ﹤0.01% | 4970 |
|
|
2022
Q4 | $58K | Buy |
13,582
+1,190
| +10% | +$5.08K | ﹤0.01% | 4693 |
|
|
2022
Q3 | $15K | Buy |
12,392
+7,257
| +141% | +$8.78K | ﹤0.01% | 4989 |
|
|
2022
Q2 | $6K | Sell |
5,135
-18,849
| -79% | -$22K | ﹤0.01% | 5269 |
|
|
2022
Q1 | $58K | Sell |
23,984
-9,503
| -28% | -$23K | ﹤0.01% | 4959 |
|
|
2021
Q4 | $90K | Buy |
33,487
+16,544
| +98% | +$44.5K | ﹤0.01% | 4876 |
|
|
2021
Q3 | $85K | Sell |
16,943
-212
| -1% | -$1.06K | ﹤0.01% | 4787 |
|
|
2021
Q2 | $128K | Sell |
17,155
-7,067
| -29% | -$52.7K | ﹤0.01% | 4684 |
|
|
2021
Q1 | $142K | Sell |
24,222
-469,743
| -95% | -$2.75M | ﹤0.01% | 4569 |
|
|
2020
Q4 | $2.32M | Sell |
493,965
-1,071,121
| -68% | -$5.03M | ﹤0.01% | 2875 |
|
|
2020
Q3 | $5.48M | Buy |
+1,565,086
| New | +$5.48M | ﹤0.01% | 2148 |
|
|
2018
Q4 | – | Sell |
-15,144
| Closed | -$34K | – | 4977 |
|
|
2018
Q3 | $34K | Buy |
+15,144
| New | +$34K | ﹤0.01% | 4475 |
|
|
2018
Q2 | – | Sell |
-6,511
| Closed | -$84K | – | 4839 |
|
|
2018
Q1 | $84K | Buy |
6,511
+5,500
| +544% | +$71K | ﹤0.01% | 3988 |
|
|
2017
Q4 | $11K | Buy |
+1,011
| New | +$11K | ﹤0.01% | 4488 |
|